SCHEMBL13304307

SCHEMBL13304307

Cc1cccc(N(c2ccccc2)c2cc3ccc4cc(N(c5ccccc5)c5cccc(C)c5)cc5ccc(c2)c3c45)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.39
▸ CYP3A4 P08684 3/20 0.39
▸ CYP2C9 P11712 3/20 0.39
▸ CYP2C19 P33261 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ CYP51A1 Q16850 1/20 0.39
▸ ACHE P22303 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ PAX8 Q06710 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304336 0.94 ACHE (0.42) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL17030411 0.94 CYP1A2 (0.45) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL13304329 0.89 MAPT (0.42) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL12722008 0.89 TDP1 (0.44) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL29462708 0.87 ACHE (0.46) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL21918074 0.87 ACHE (0.46) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL26033132 0.87 ACHE (0.46) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL332284 0.87 ACHE (0.46) TDP1CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL14342109 0.87 ACHE (0.46) TDP1CYP3A4CYP2C9CYP2C19MAPT
Benzene SCHEMBL13561466 0.87 ACHE (0.50) TDP1CYP3A4CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1437395-B2 Organic electroluminescent device LG DISPLAY CO LTD (KR) 2015-08-26 — — EP disclosed
US-8436344-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2013-05-07 — — US disclosed
EP-1437395-B1 Organic electroluminescent device LG DISPLAY CO LTD (KR) 2011-12-14 — — EP disclosed
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2010-06-24 — — US disclosed
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2010-06-24 — — US disclosed
US-7700201-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-04-20 — — US disclosed
US-7700201-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2010-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100155714-A1 ORGANIC ELECTROLUMINESCENT DEVICE L1CAM, AOC2, AOC1 TDP1 2403/4885CYP3A4 864/4885CYP2C9 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback